SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                                   ----------

                                    FORM 8-K

                                 CURRENT REPORT
                       PURSUANT TO SECTION 13 OR 15(D) OF
                       THE SECURITIES EXCHANGE ACT OF 1934


       Date of Report (Date of earliest event reported) October 11, 2006
                                                        ----------------


                                ICU MEDICAL, INC.
             (Exact name of registrant as specified in its charter)

          DELAWARE                     0-19974                   33-0022692
          --------                     -------                   ----------
(State or other jurisdiction   (Commission File Number)      (I.R.S. Employer
      of incorporation)                                     Identification No.)

   951 Calle Amanecer, San Clemente, California                      92673
   --------------------------------------------                      -----
     (Address of principal executive offices)                     (Zip Code)

                                 (949) 366-2183
                                 --------------
               Registrant's telephone number, including area code


                                       N/A
                                       ---
          (Former name or former address, if changed since last report)

     Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):

     |_| Written communications pursuant to Rule 425 under the Securities Act
         (17 CFR 230.425)

     |_| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
         CFR 240.14a-12)

     |_| Pre-commencement communications pursuant to Rule 14d-2(b) under the
         Exchange Act (17 CFR 240.14d-2(b))

     |_| Pre-commencement communications pursuant to Rule 13e-4(c) under the
         Exchange Act (17 CFR 240.13e-4(c))



                    INFORMATION TO BE INCLUDED IN THE REPORT


Item 8.01      Other Events
               ------------

               See attached press release.

Item 9.01      Financial Statements and Exhibits
               ---------------------------------

     (c)       Exhibits

     99.1      Press release, dated October 11, 2006, announcing ICU Medical,
               Inc.'s third quarter 2006 earnings conference call.


                                   SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this Report to be signed on its behalf by the
undersigned hereunto duly authorized.

Date: October 11, 2006

                                ICU MEDICAL, INC.


                                /s/ Francis J. O'Brien
                                ----------------------
                                Francis J. O'Brien
                                Secretary, Treasurer and
                                Chief Financial Officer